DENISE CARCAMO: Open Payments
NPI 1588993315 · RAPID CITY, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$392 in 14 payments from 8 companies in 2025. Trend: 2023 $438 · 2024 $455 · 2025 $392
Food & beverage: $392
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $141 |
| ABBVIE INC. | 4 | $121 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| E.R. Squibb & Sons, L.L.C. | 2 | $32 |
| PFIZER INC. | 1 | $20 |
| Merck Sharp & Dohme LLC | 1 | $17 |
| Novo Nordisk Inc | 1 | $15 |
| Amgen Inc. | 1 | $14 |
Products named: UBRELVY, TEZSPIRE, TRELEGY ELLIPTA, PREVNAR 20, QULIPTA, GARDASIL 9, ELIQUIS, CAMZYOS.
Industry payments across SD — which companies pay providers there.
